Tag: DBT
DBT & BIRAC announce a joint call for proposals on Bio-AI...
Bio-AI hubs are proposed to be established across academia and industry to provide critical and novel research leads
India unveils indigenous HPV tests to strengthen cervical cancer screening
Union Minister Dr Jitendra Singh unveils cost-effective, homegrown diagnostic solutions backed by DBT-BIRAC-GCI initiative
Experts discuss IP & tech transfer best practices at World IP...
The event was supported by the National Biopharma Mission, BIRAC, and Institution’s Innovation Council (IIC)
DBT partners Oxford Nanopore to launch two Genomic Centres of Excellence...
Institutes under the Department of BioTechnology (DBT) sign Letters of Intent with Oxford Nanopore to establish next-generation Genomic Centres of Excellence and new suite of R&D collaborations including in rare disease, newborn screening, oral cancer, and antimicrobial resistance (AMR) studies
DBT & BIRAC host webinar on biomanufacturing & biofoundry initiative on...
The webinar provided a platform for academia, industry leaders, start-ups, and researchers to discuss advancements, as well as, opportunities in Cell and Gene Therapy
India highlights its BioE3 policy & Integrated Biorefinery Initiatives at Mission...
The participants highlighted how the BioE3 Policy promotes sustainable and low-carbon manufacturing of fuels, chemicals, and materials
FACE TO FACE: Dr Taslimarif Saiyed, Director and CEO, Centre for Cellular...
Taslimarif Saiyed, Director and CEO, Centre for Cellular and Molecular Platforms (C-CAMP) talks about the relevance of Startup Mahakumbh event, key factors driving startup ecosystem, latest trends, challenges and much more.
Union govt to collaborate with States to establish regional BIRAC centers...
Mapping of States based on their biotech potential and collaborating to set up Bio E3 Cells
BIRAC Turns 13: Dr Jitendra Singh releases India Bioeconomy Report 2025
India's bio-economy has witnessed a remarkable 16-fold rise in 10 years of the past one decade, from $ 10 Billion in 2014 to an impressive $165.7 Billion in 2024, claimed the Minister
Dr Rajesh Gokhale delivers lecture at CSIR-IMTECH’s 41st Foundation Day
As part of the celebrations, CSIR-IMTECH signed several MOUs’ with pharma industries for usage of Biofoundry to aid rapid development of precision biotherapeutics and early scaling up of proof of concept of biomolecules